The importance of removing interference caused by Darzalex® (daratumumab) in pre-transfusion testing. JHSCI [Internet]. 2024 Feb. 25 [cited 2025 Jun. 5];13(3 (Suplement 1):243-5. Available from: http://jhsci.ba/ojs/index.php/jhsci/article/view/2612